RNAIMMUNE
RNAimmune is a biopharmaceutical company specializing in the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. The company leverages mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases. RNAimmune is a spin-off venture from Sirnaomics, Inc. has received a global exclusive right to the proprietary Polypeptide Lipid Nanoparticle (PLNP) technology for mRNA delivery from Sirnaomics. The company has also ... developed a proprietary A.I. algorithm (ALEPVA) for antigen prediction and vaccine design. By integrating multiple established platform technologies, the company is aiming to develop a comprehensive mRNA drug discovery and development platform, from which the company will enrich its therapeutic and vaccine product pipeline addressing tremendous unmet needs in treatments of viral infections, cancer, and rare diseases.
RNAIMMUNE
Industry:
Biotechnology Health Care Life Science
Founded:
2020-01-01
Address:
Gaithersburg, Maryland, United States
Country:
United States
Website Url:
http://www.rnaimmune.com
Total Employee:
1+
Status:
Active
Total Funding:
39.35 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Similar Organizations
BIOMES
BIOMES is a biotechnological pioneer that specializes in improving everyones wellbeing by analyzing and interpreting the human microbiome.
Brain Neurotherapy Bio
Brain Neurotherapy Bio focuses on the clinical translation and development of neurotrophic factor gene therapy.
Cell Vault
Cell Vault offers a t-cell bank that gives healthy individuals an opportunity to jumpstart their fight against cancer.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Evommune
Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines.
ExcepGen
ExcepGen is solving fundamental underlying problems in drug discovery to create a new generation of therapeutics.
Gossamer Bio
Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.
Hive
Hive Biosystems helps pharmaceutical companies streamline genetics-driven drug discovery by rapidly generating transgenic animals.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
MRM Health NV
MRM Health NV is a biopharmaceutical company focused on the discovery and development of therapeutics based on the human microbiome.
Ona Therapeutics
Ona Therapeutics is focused on the discovery and development of therapeutic biologics to treat metastatic cancer.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Rubix LS
Rubix LS primary goal is to eradicate rare diseases through transformative research and development, breakthroughs in engineering.
SeromYx Systems
SeromYx Systems provides insight into the immune function to discover and develop vaccines, immunotherapies, drugs, and diagnostics.
Current Advisors List
Board_member
2022-03-29
Current Employees Featured
Nigel Yip CFO @ RNAimmune
CFO
Kevin He Chief Medical Officer @ RNAimmune
Chief Medical Officer
Dong Shen Founder & CEO @ RNAimmune
Founder & CEO
Stanley He Chief Business Officer @ RNAimmune
Chief Business Officer
Founder
Investors List
Rotating Boulder Fund
Rotating Boulder Fund investment in Series A - RNAimmune
Sirnaomics
Sirnaomics investment in Series A - RNAimmune
Smooth River
Smooth River investment in Series A - RNAimmune
Sirnaomics
Sirnaomics investment in Seed Round - RNAimmune
Smooth River
Smooth River investment in Seed Round - RNAimmune
Terra Magnum Capital Partners (""""TMCP"""")""
Terra Magnum Capital Partners (""""TMCP"""")"" investment in Seed Round - RNAimmune
Official Site Inspections
http://www.rnaimmune.com Semrush global rank: 4.24 M Semrush visits lastest month: 2.76 K
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "RNAimmune"
RNAimmune
RNAimmune is a biotechnology startup in the field of messenger RNA (mRNA) technology with more than 20 years’ expertise in handling and optimizing this versatile molecule for medical …See details»
RNAimmune - Crunchbase Company Profile & Funding
RNAimmune is a biopharmaceutical company specializing in the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. The …See details»
RNAimmune 2025 Company Profile: Valuation, Funding
Rotating Boulder Fund, High Forest Investment, Hong Kong Hongrun, Shanghai Walga Biotechnology, and Sirnaomics are 5 of 7 investors who have invested in RNAimmune. Who …See details»
RNAimmune Company Profile | Management and Employees List
Find contact information for RNAimmune. Learn about their Research & Development, Business Services market share, competitors, and RNAimmune's email format.See details»
RNAimmune - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Apr 21, 2021: Seed Round - …See details»
RNAimmune - The Org
RNAimmune is a biotechnology startup in the field of messenger RNA (mRNA) technology with more than 20 years’ expertise in handling and optimizing this versatile molecule for medical …See details»
RNAimmune - LinkedIn
At RNAimmune, we use mRNA technology to help people live full and healthy lives. Our primary focus is development of vaccines against cancer and respiratory viruses.See details»
Rnaimmune, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
About RNAimmune RNAimmune is a pioneering biotech company dedicated to developing mRNA-based therapeutics and vaccines. With its global headquarters in Germantown, …See details»
RNAimmune Company Profile - Office Locations, Competitors
RNAimmune is a biotechnology company that focuses on RNA (mRNA) technology It offers RNA technology as a data carrier to instruct the human body to produce its proteins capable of …See details»
RNAimmune, Inc. Company Information - Funding, Investors, and …
Get information on funding, investors, industries, and more for RNAimmune, Inc.. See RNAimmune, Inc. company profile and funding data.See details»
RNAimmune - VentureRadar
RNAimmune is a biotechnology startup in the field of messenger RNA (mRNA) technology with more than 20 years’ expertise in handling and optimizing this versatile molecule for medical …See details»
RNAimmune - Contacts, Employees, Board Members, Advisors
RNAimmune is a biopharmaceutical company specializing in the discovery and development of mRNA-based therapeutics and vaccines. ... Experience the new Crunchbase, powered by AI . …See details»
RNAimmune - Overview, News & Similar companies | ZoomInfo.com
Dec 17, 2023 RNAimmune, founded in 2020 in Gaithersburg, Maryland, is a biopharmaceutical company specializing in discovery and development of messenger RNA (mR NA) therapeutics …See details»
RNAimmune Company Profile: Overview and Full News Analysis
RNAimmune is a biotechnology startup based in Maryland, specializing in messenger RNA (mRNA) technology for medical applications. With over 20 years of expertise in mRNA …See details»
RNAimmune mRNA Cancer Vaccine Program Accepted for Oral …
Feb 6, 2023 RNAimmune Inc. is an international biopharmaceutical company focusing on mRNA vaccine and therapeutics development. Its global headquarters are located in Germantown, …See details»
Rnaimmune Inc. - BioCentury Company Profiles - BCIQ
Mar 31, 2022 Rnaimmune Inc. - BioCentury Company Profiles for the biopharma industrySee details»
RNAimmune mRNA Cancer Vaccine Program Accepted for Oral
Feb 6, 2023 RNAimmune, Inc. announced today that its RNAimmune mRNA cancer vaccine program has been accepted for oral presentation at the AACR Annual Meeting 2023. ... Found …See details»
RNAimmune closes $2.35m seed funding for development of …
RNAimmune, Inc., a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, announced the completion of its $2.35 million seed …See details»
RNAimmune - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. RNAimmune . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 2. Monthly Visits 1,202. …See details»
Sirnaomics Announces Decision to Spin off RNAimmune to
Jun 11, 2020 RNAimmune expects to emerge as one of the leading groups for vaccine development against COVID-19 with unique mRNA vaccine ... The company’s leading product …See details»